Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate

被引:7
|
作者
Visciano, Maria Luisa [1 ]
Tagliamonte, Maria [1 ]
Stewart-Jones, Guillaume [2 ]
Heyndrickx, Leo [3 ]
Vanham, Guido [3 ]
Jansson, Marianne [4 ]
Fomsgaard, Anders [5 ]
Grevstad, Berit [5 ]
Ramaswamy, Meghna [6 ]
Buonaguro, Franco M. [1 ]
Tornesello, Maria Lina [1 ]
Biswas, Priscilla [7 ]
Scarlatti, Gabriella [7 ]
Buonaguro, Luigi [1 ]
机构
[1] IRCCS, Fdn Pascale, Ist Nazl Studio & Cura Tumori, Mol Biol & Viral Oncogenesis Unit,Dept Expt Oncol, Naples, Italy
[2] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England
[3] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium
[4] Lund Univ, Dept Lab Med, Lund, Sweden
[5] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[6] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England
[7] Ist Sci San Raffaele, I-20132 Milan, Italy
来源
JOURNAL OF TRANSLATIONAL MEDICINE | 2013年 / 11卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN COMPLEX; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZING ANTIBODIES; MONOMERIC GP120; IMMUNOGENICITY; PARTICLES; EPITOPE; SUBTYPE; BREADTH;
D O I
10.1186/1479-5876-11-165
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
    Maria Luisa Visciano
    Maria Tagliamonte
    Guillaume Stewart-Jones
    Leo Heyndrickx
    Guido Vanham
    Marianne Jansson
    Anders Fomsgaard
    Berit Grevstad
    Meghna Ramaswamy
    Franco M Buonaguro
    Maria Lina Tornesello
    Priscilla Biswas
    Gabriella Scarlatti
    Luigi Buonaguro
    Journal of Translational Medicine, 11
  • [2] Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses
    Cranage, M. P.
    Fraser, C. A.
    Stevens, Z.
    Huting, J.
    Chang, M.
    Jeffs, S. A.
    Seaman, M. S.
    Cope, A.
    Cole, T.
    Shattock, R. J.
    MUCOSAL IMMUNOLOGY, 2010, 3 (01) : 57 - 68
  • [3] Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
    P Spearman
    G Tomaras
    D Montefiori
    Y Huang
    H Ahmed
    M Elizaga
    J Hural
    J McElrath
    L Ouedraogo
    M Pensiero
    C Butler
    S Kalams
    ET Overton
    S Barnett
    N Group
    Retrovirology, 9
  • [4] Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
    Spearman, P.
    Tomaras, G.
    Montefiori, D.
    Huang, Y.
    Ahmed, H.
    Elizaga, M.
    Hural, J.
    McElrath, J.
    Ouedraogo, L.
    Pensiero, M.
    Butler, C.
    Kalams, S.
    Overton, E. T.
    Barnett, S.
    Group, N.
    RETROVIROLOGY, 2012, 9
  • [5] Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins
    Sellhorn, George
    Kraft, Zane
    Caldwell, Zachary
    Ellingson, Katharine
    Mineart, Christine
    Seaman, Michael S.
    Montefiori, David C.
    Lagerquist, Eliza
    Stamatatos, Leonidas
    JOURNAL OF VIROLOGY, 2012, 86 (01) : 128 - 142
  • [6] Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens
    Derby, Nina R.
    Gray, Sean
    Wayner, Elizabeth
    Campogan, Dwayne
    Vlahogiannis, Giorgos
    Kraft, Zane
    Barnett, Susan W.
    Srivastava, Indresh K.
    Stamatatos, Leonidas
    VIROLOGY, 2007, 366 (02) : 433 - 445
  • [7] A Trimeric HIV-1 gp140-BAFF Fusion Construct Enhances Mucosal Anti-trimeric HIV-1 gp140 IgA in Mice
    Liu, J.
    Clayton, K.
    Li, Y.
    Haaland, M.
    Schwartz, J.
    Sivanesan, H.
    Saiyed, A.
    Bozorgzad, A.
    Zhan, W.
    Yue, F.
    Rini, J.
    Ostrowski, M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A160 - A160
  • [8] Vaginal Delivery of a Recombinant HIV-1 Clade-C Trimeric gp140 within Novel Rheologically Structured Vehicles Induces Specific Immune Responses
    Curran, R. M.
    Donnelly, L.
    Morrow, R.
    Andrews, G.
    Malcolm, K. R.
    Woolfson, D. A.
    Wegmann, F.
    Sattentau, Q.
    Cranage, M.
    Fraser, C.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 151 - 151
  • [9] A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120
    Beddows, Simon
    Franti, Michael
    Dey, Antu K.
    Kirschner, Marc
    Iyer, Sal Prasad N.
    Fisch, Danielle C.
    Ketas, Thomas
    Yuste, Eloisa
    Desrosiers, Ronald C.
    Klasse, Per Johan
    Maddon, Paul J.
    Olson, William C.
    Moore, John P.
    VIROLOGY, 2007, 360 (02) : 329 - 340
  • [10] Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice
    Liu, Jun
    Clayton, Kiera
    Gao, Wenbo
    Li, Yu
    Zealey, Chris
    Budylowski, Patrick
    Schwartz, Jordan
    Yue, Feng Yun
    Bie, Yuan
    Rini, James
    Ostrowski, Mario
    VACCINE, 2020, 38 (09) : 2149 - 2159